What is the significance of a nodule appearing 1 month after partial nephrectomy for stage 1 Chromophobe Renal Cell Carcinoma (RCC) located in the fat anterior to the psoas muscle below the lower pole of the left kidney, still visible on Computed Tomography (CT) imaging 3 years later?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The appearance of a nodule one month after partial nephrectomy for stage 1 chromophobe renal cell carcinoma (RCC) that remains visible on CT imaging for three years warrants further evaluation, and I recommend a biopsy of this nodule to determine if it represents recurrent cancer or benign tissue. The location in the fat anterior to the psoas muscle below the lower pole of the left kidney is concerning for potential local recurrence, though the stability over three years is somewhat reassuring 1. According to the ACR Appropriateness Criteria, most recurrences occur within 3 years after treatment, with a median time to relapse of 1 to 2 years, and the lungs are the most common site affected by metastases, followed by the lymph nodes, bones, liver, adrenal glands, and brain 1.

Key Considerations

  • The patient's history of stage 1 chromophobe RCC and partial nephrectomy
  • The nodule's location and stability over three years
  • The need for thorough investigation to exclude malignancy
  • The potential for benign processes, such as scar tissue

Recommended Course of Action

  • Biopsy of the nodule to determine if it represents recurrent cancer or benign tissue
  • If malignancy is confirmed, surgical excision would likely be recommended, potentially followed by surveillance imaging every 3-6 months for the first two years
  • If benign, continued annual surveillance imaging would be appropriate
  • Discussion with a urologic oncologist to develop a personalized management plan 1

Rationale

The American Society of Clinical Oncology clinical practice guideline recommends that any new nodule appearing post-surgery requires thorough investigation, and that chromophobe RCC typically has a favorable prognosis with low recurrence rates after complete resection 1. However, the stability of the nodule over three years suggests it may be scar tissue or a benign process, but malignancy cannot be excluded without tissue sampling. Therefore, a biopsy is necessary to determine the nature of the nodule and guide further management.

From the Research

Significance of a Nodule after Partial Nephrectomy

  • The appearance of a nodule 1 month after partial nephrectomy for stage 1 Chromophobe Renal Cell Carcinoma (RCC) located in the fat anterior to the psoas muscle below the lower pole of the left kidney, still visible on Computed Tomography (CT) imaging 3 years later, may indicate a potential recurrence or residual tumor 2, 3.
  • Chromophobe RCC is a subtype of renal cell carcinoma with a generally favorable prognosis, but a subset of patients may experience disease progression 2.
  • The presence of a nodule in the fat anterior to the psoas muscle may suggest a possible local recurrence, which is a known complication of partial nephrectomy 2, 3.

Prognostic Factors

  • Tumor size, pT stage, broad alveolar architecture, Fuhrman nuclear grade, microscopic tumor necrosis, vascular invasion, and sarcomatoid change are associated with disease progression in chromophobe RCC 2.
  • The presence of sarcomatoid change, microscopic necrosis, and high pT stage are independent predictors of aggressive chromophobe RCC 2.

Diagnostic Challenges

  • Distinguishing between renal oncocytoma and chromophobe RCC can be challenging due to their similar cellular origin and overlapping CT features 4.
  • CT imaging features such as location, tumor size, relative density ratio, segmental enhancement inversion, necrosis, and perirenal fascia thickening can be useful in differentiating between renal oncocytoma and chromophobe RCC 4.

Clinical Implications

  • Regular follow-up with CT imaging is essential for monitoring patients after partial nephrectomy for chromophobe RCC 5, 6.
  • The presence of a nodule after partial nephrectomy warrants further evaluation and potential biopsy to determine the nature of the lesion 2, 3.

Related Questions

What is the significance of a persistent 3 mm nodule anterior to the psoas muscle, adjacent to the left kidney, after partial nephrectomy for Chromophobe renal cell carcinoma (RCC)?
What is the significance of a 3 mm nodule found in the fat anterior to the psoas muscle below the lower pole of the left kidney on 3-year imaging, initially reported as new but later determined to be present 1.5 months following partial nephrectomy for a 1.3 cm Chromophobe Renal Cell Carcinoma (RCC)?
What is the significance of a 3 mm nodule found in the fat anterior to the psoas muscle, below the lower pole of the left kidney, on imaging 3 years after a partial nephrectomy for a 1.3 cm exophytic Chromophobe renal cell carcinoma (RCC)?
What is the clinical significance of a 3mm nodule in the fat anterior to the psoas muscle, which appeared after partial nephrectomy (partial removal of the kidney) for a 1.3cm chromophobe renal cell carcinoma (RCC), and has been stable on subsequent scans?
What is the significance of a 1.5 cm mass in the perinephric space adjacent to the surgical bed, 3 years after partial nephrectomy for a 1.3 cm chromophobe renal cell carcinoma (RCC) T1a?
What is the diagnosis for a patient presenting with cellulitis, oral ulcers, and arthralgia while taking Augmentin (amoxicillin-clavulanate)?
Is a 3 mm nodule appearing 1 month after partial nephrectomy for stage 1 Chromophobe Renal Cell Carcinoma (RCC) located in the fat anterior to the psoas muscle below the lower pole of the left kidney concerning for a metastatic lymph node or a benign finding?
What is the diagnosis for a patient presenting with periorbital cellulitis, oral ulcers, and arthralgia while taking Augmentin (amoxicillin-clavulanate)?
What is the significance of a persistent 3mm nodule in the fat anterior to the psoas muscle, below the lower pole of the left kidney, 3 years after partial nephrectomy for stage 1 Chromophobe Renal Cell Carcinoma (RCC)?
Is a 3mm nodule, visible on CT imaging 3 years after partial nephrectomy for stage 1 Chromophobe Renal Cell Carcinoma (RCC), located in the fat anterior to the psoas muscle below the lower pole of the left kidney, likely benign?
What is invasive pneumococcal disease (Invasive Streptococcus pneumoniae infection)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.